Recurrent Visceral Leishmaniasis in HIV Co-Infection

Recruiting now

Conditions studied: Hiv, Visceral Leishmaniasis

In brief

The aim is (1) to better understand the underlying causes and predispositions for relapse and parasite persistence in visceral leishmaniasis (VL) patients living with HIV and (2) to improve treatment monitoring of this target group in Ethiopia

Key facts

Study ID

NCT07487350

Run by

Institute of Tropical Medicine, Belgium

People needed

20

Starts

2025-10-21

Expected to finish

2027-12-01

Last updated by the study team

2026-03-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• VL-HIV infection 1.1. VL: microscopically confirmed parasite presence in spleen or bone marrow tissue at first episode or relapse; for known active chronic cases: decision to treat VL 1.2. HIV: confirmed viral infection (new or past)
• ≥18 years

You may not qualify if…

• Not willing to provide written informed consent
• Not willing to adhere to the follow-up visits
• Mentally or physically incapable to participate in the study (to the discretion of the treating physician)

Where it is running

• University of Gondar — Gonder, Ethiopia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.